Related Experiment Videos
Angioplasty in the diabetic patient
Eric Van Belle1, Akram Chmaït, Christophe Bauters
1Service de Cardiologie B et Hemodynamique, Hopital Cardiologique, Lille Cedex, France.
Insights
Diabetic patients face higher risks with coronary artery disease and revascularization. This review examines percutaneous coronary intervention (PCI) effectiveness and advancements for improved outcomes in diabetics.
Area of Science:
- Cardiology
- Diabetology
Background:
- Diabetes mellitus significantly elevates the risk of coronary artery disease (CAD).
- Diabetic patients experience higher mortality and morbidity following coronary revascularization procedures.
Purpose of the Study:
- To review current information on percutaneous coronary intervention (PCI) in diabetic patients.
- To evaluate the effectiveness of PCI in managing CAD in this high-risk population.
Main Methods:
- Literature review of available information on PCI in diabetic patients.
- Exploration of factors influencing PCI outcomes in diabetes.
- Evaluation of recent PCI advancements, including stents, drug-eluting stents, glycoprotein IIb/IIIa inhibitors, and brachytherapy.
Main Results:
- PCI effectiveness in diabetic patients is discussed.
- Factors impacting PCI outcomes in this group are explored.
- The role of novel PCI technologies in improving prognosis is assessed.
Conclusions:
- Percutaneous coronary intervention (PCI) offers a treatment option for diabetic patients with coronary artery disease.
- Understanding influencing factors and advancements is crucial for optimizing PCI outcomes in diabetics.
- Emerging technologies show promise for improving the prognosis of diabetic patients undergoing PCI.
Abstract:
Patients with diabetes have an increased risk of coronary artery disease, and are at an increased risk of mortality and morbidity with coronary revascularization procedures. This article provides a review of the currently available information on percutaneous coronary intervention (PCI) in the diabetic patient. The effectiveness of PCI in diabetes is discussed, and the factors that may influence outcomes are explored. Recent developments in PCI procedures, such as stents and drug-eluting stents, glycoprotein IIb/IIIa inhibitors and brachytherapy, are evaluated in terms of their ability to improve the prognosis in this patient group.